Koninklijke DSM Euronext Amsterdam

Equities

DSM

NL0000009827

Consumer Goods Conglomerates

Market Closed - Euronext Amsterdam 16:35:24 30/05/2023 BST 5-day change 1st Jan Change
114 EUR +0.13% Intraday chart for Koninklijke DSM -.--% -.--%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
DSM-Firmenich Unit Issues EUR800 Million Bond MT
DSM-Firmenich Issues ?800 Million Long-Term Bond CI
DSM-Firmenich Launches Voluntary Transfer Offer for Remaining DSM Shares MT
DSM-Firmenich AG made a Voluntary transfer of offer to acquire remaining shares in DSM B.V. CI
Dsm-firmenich to Sell Yeast Extract Business to France's Lesaffre MT
Lesaffre et Compagnie, SA agreed to acquire Yeast Extract Business of DSM-Firmenich. CI
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices RE
Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft... Our Logo
Transcript : DSM-Firmenich AG - Analyst/Investor Day
Dsm-firmenich to De-prioritize Certain Business Activities Under New Strategy MT
DSM-Firmenich sees mid-term adjusted EBITDA margin of 22-23% RE
Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal MT
Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements MT
Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board CI
Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 CI
Tranche Update on DSM-Firmenich AG's Equity Buyback Plan announced on April 8, 2024. CI
DSM-Firmenich AG's Equity Buyback announced on April 8, 2024, has closed with 1,500,000 shares, representing 0.57% for ?156.59 million. CI
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple... Our Logo
DSM-FIRMENICH : Vitamin trouble is going to fade Alphavalue
U.S. Futures Up, European Stocks Mixed in Wake of Fed Remarks DJ
Transcript : DSM-Firmenich AG, Q1 2024 Sales/ Trading Statement Call, May 02, 2024
U.S. Futures Down, European Stocks Mixed DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. CI
DSM-Firmenich AG authorizes a Buyback Plan. CI
DSM-FIRMENICH : A stronger long-term outlook Alphavalue
Chart Koninklijke DSM
More charts
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.6 EUR
Average target price
122.9 EUR
Spread / Average Target
+16.35%
Consensus
  1. Stock Market
  2. Equities
  3. DSFIR Stock
  4. DSM Stock
  5. News Koninklijke DSM
  6. DSM-Firmenich to Scrap Co-CEO Structure After Merger